HDL and glucose metabolism: Current evidence and therapeutic potential

• Egile Nagusiak: Andrew Lloyd Siebel (Egilea), Sarah Enid Heywood (Egilea), Bronwyn Anne Kingwell (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2015-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

High-density lipoprotein (HDL) and its principal apolipoprotein A-I (ApoA-I) have now been convincingly shown to influence glucose metabolism through multiple mechanisms. The key clinically relevant observations are that both acute HDL elevation via short-term reconstituted HDL (rHDL) infusion and c...